|
|
Sotera Health Company (NASDAQ: SHC) |
|
Price: $10.6400
$0.33 
3.151%
|
| Day's High:
| $10.67
| Week Perf:
| 0.19 %
|
| Day's Low: |
$ 10.37 |
30 Day Perf: |
-11.11 % |
| Volume (M): |
1,567 |
52 Wk High: |
$ 17.08 |
| Volume (M$): |
$ 16,668 |
52 Wk Avg: |
$13.36 |
| Open: |
$10.43 |
52 Wk Low: |
$9.53 |
|
|
| Market Capitalization (Millions $) |
2,952 |
| Shares
Outstanding (Millions) |
277 |
| Employees |
8,519 |
| Revenues (TTM) (Millions $) |
1,100 |
| Net Income (TTM) (Millions $) |
44 |
| Cash Flow (TTM) (Millions $) |
-23 |
| Capital Exp. (TTM) (Millions $) |
179 |
Sotera Health Company
Sotera Health is a leading global provider of critical solutions for the healthcare industry.
The company was founded in 2015 and is headquartered in Broadview Heights, Ohio, US.
Sotera Health services a wide range of industries including medical device, pharmaceutical, tissue and implant industries.
Sotera Health operates through three primary business segments: Sterigenics, Nordion, and Nelson Labs.
Sterigenics is a leading provider of contract sterilization services for medical devices and pharmaceutical products.
Sterigenics operates through multiple facilities in North America, Europe, and Asia.
Nordion is a leading supplier of Cobalt-60, a radioactive isotope used in the sterilization of medical equipment and supplies.
Nordion is the only supplier of Cobalt-60 to the global market, supplying over 70% of the world's needs.
Nelson Labs is a leading provider of testing and consulting services for the medical device and pharmaceutical industries.
The company provides microbiology and analytical chemistry testing, biocompatibility testing, and toxicology consulting services, among others.
Sotera Health's mission is to provide safe, effective, and innovative solutions to support the healthcare industry in improving patient outcomes.
The company is committed to high standards of quality, safety, and compliance across all of its operations.
Sotera Health has a global presence with operations in more than 50 countries.
The company employs over 2,800 team members worldwide.
Sotera Health is also committed to sustainability and corporate responsibility.
The company has implemented various programs to reduce its environmental impact and promote social responsibility, including reducing carbon emissions, waste reduction, and community outreach initiatives.
Overall, Sotera Health is a leading provider of critical solutions for the healthcare industry, offering a wide range of services that support the development and delivery of safe and effective medical products.
The company's dedication to quality, safety, and compliance, as well as its commitment to sustainability and corporate responsibility, make it a trusted partner for healthcare companies worldwide.
Company Address: 9100 South Hills Blvd Broadview Heights 44147 OH
Company Phone Number: 262-1410 Stock Exchange / Ticker: NASDAQ SHC
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Shares
Published Wed, Sep 4 2024 8:42 PM UTC
Sotera Health Announces Secondary Offering of Common Stock
Cleveland, Sept. 04, 2024 - Sotera Health Company (Nasdaq: SHC) disclosed today the launch of a secondary offering of 25,000,000 shares of its common stock. The offering is being made by certain affiliates of Warburg Pincus LLC (Warburg Pincus) and GTCR LLC (GTCR) as selling stockholders. The company s sponsors, ...
|
| Financing Agreement
Published Thu, May 30 2024 9:12 PM UTC
Sotera Health Secures $2.25 Billion in Financing to Strengthen Position in Healthcare Industry
Sotera Health, a global leader in sterilization solutions and lab testing services for the healthcare sector, has announced the successful closing of $1.5 billion in Term Loan B financing and $750 million in senior secured notes. This significant financing will allow the compan...
|
| Sotera Health Company
Sotera Health Company has experienced a decline in its stock value over the past 30 days, with a decrease of 6.74%. Looking back over the year, the stock has declined even further, dropping by 31.75%. These results indicate some challenges that the company has faced in maintaining investor confidence.
The recent financial results provide some insights into the factors contributing to the decline in stock value. Sotera Health Company reported an increase in income per share by 100% to $0.02 per share, along with a revenue increment of 12.478% to $248.12 million compared to the previous year. These results are positive indicators of the company's performance.
|
| Sotera Health Company
The financial results of Sotera Health Company for the fourth quarter and full-year 2023 are quite impressive, showing strong revenue growth and a significant improvement in profitability. The company reported a 23.612% increase in revenue to $311.00 million, leading to earnings per share of $0.13 compared to a loss of $1.14 per share in the same period last year. The company also saw a sequential increase in income per share from a loss of $0.05 per share and a growth in revenue of 18.257% from the previous quarter.
The most notable achievement for Sotera Health Company was turning a net income of $38.681 million in the fourth quarter of 2023, a significant improvement from a net loss of $319.719 million in the same quarter a year ago. The company also highlighted its improving profit margins, with a net margin of 12.44% and an operating margin of 33.45% in the fiscal year ending December 31, 2023. This is a positive sign for investors as it indicates that the company is effectively managing its costs and increasing its profitability.
|
| Financing Agreement
Published Tue, Feb 27 2024 10:30 PM UTC
Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, Feb. 27, 2024 - Sotera Health Company has recently launched a secondary offering of 25,000,000 shares of its common stock. The shares are being offered for sale by selling stockholders, including affiliates of Warburg Pincus LLC and GTCR, LLC, as well as two members of management and one member of the ...
|
| Per Share |
Current |
| Earnings (TTM) |
0.15 $ |
| Revenues (TTM) |
3.97 $
|
| Cash Flow (TTM) |
- |
| Cash |
1 $
|
| Book Value |
1.46 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
0.15 $
|
| Revenues (TTM) |
3.97 $ |
| Cash Flow (TTM) |
- |
| Cash |
1 $
|
| Book Value |
1.46 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Point in time |
|
 79.59 % |
of total Revenue |
| Over time |
|
20.57 % |
of total Revenue |
| Sterigenics |
|
61.6 % |
of total Revenue |
| Sterigenics Point in time |
|
61.6 % |
of total Revenue |
| Nordion |
|
18 % |
of total Revenue |
| Nordion Point in time |
|
17.99 % |
of total Revenue |
| Nordion Over time |
|
0.02 % |
of total Revenue |
| Nelson Labs |
|
20.55 % |
of total Revenue |
| Nelson Labs Over time |
|
20.55 % |
of total Revenue |
| Intersegment |
|
-5.3 % |
of total Revenue |
| |
On February 27 2025 the Sotera Health provided following guidance
Sotera Health Company has announced its financial outcomes for the fourth quarter and the entire year of 2024, while also offering its preliminary projections for 2025. As a prominent global provider, Sotera Health specializes in essential sterilization solutions, laboratory testing, and advisory services tailored for the healthcare sector. The report, released on February 27, 2025, indicates that the firm has laid out specific estimates for its performance in 2025. However, comprehensive details regarding these projections have not yet been disclosed.
In the statement issued from Cleveland, the company reaffirmed its commitment to delivering critical services that meet the rigorous demands of the h...
|
|
|
2.78%